CJC-1295 and Ipamorelin blended research peptide 10mg vial by SBR Labs

CJC-1295 / Ipamorelin Blend 10mg

Cjc 5mg/ Ipa 5mg
$59.99
Sale price  $59.99 Regular price 
Skip to product information
CJC-1295 and Ipamorelin blended research peptide 10mg vial by SBR Labs

CJC-1295 / Ipamorelin Blend 10mg

$59.99
Sale price  $59.99 Regular price 
StrengthCjc 5mg/ Ipa 5mg
  • ✓ Third-Party Tested — View COAs
  • ✓ Research-Grade Handling — Careful order handling
  • ✓ Refund Policy — See policy
  • ✓ Research Use Only — For laboratory research

CJC-1295 / Ipamorelin Blend 10mg — dual GHRH-analog + GHS receptor agonist

The CJC-1295 / Ipamorelin Blend combines two complementary growth hormone secretagogue (GHS) peptides in a single lyophilized vial: CJC-1295, a synthetic long-acting analog of growth hormone-releasing hormone (GHRH), and Ipamorelin, a selective pentapeptide agonist of the ghrelin receptor (GHS-R1a). The pairing is studied in preclinical research on the growth hormone / IGF-1 axis, pituitary somatotroph signaling, and receptor-selective secretagogue pharmacology.

Certificate of analysis — current lot on file

  • Product: CJC-1295 / Ipamorelin Blend
  • Laboratory: Janoshik (independent third party)
  • Task number: 200525
  • Reported batch: CP10260616
  • Reported content: CJC-1295 (no DAC) 4.89mg; Ipamorelin 4.54mg
  • Report date: July 7, 2026

Verify this report with the lab: open the original Janoshik report. It is also listed on the SBR Labs Certificates of Analysis page. To check the identity, lot, and purity fields yourself, see how to read a peptide certificate of analysis and how to verify peptide purity reports.

For laboratory research use only. Not for human or animal consumption.

Product specifications

  • Contents: CJC-1295 5mg + Ipamorelin 5mg per vial (10mg total peptide)
  • CJC-1295 sequence: tetrasubstituted GRF(1-29) analog; DAC-conjugated variants extend plasma half-life
  • Ipamorelin sequence: Aib-His-D-2-Nal-D-Phe-Lys-NH2 (pentapeptide)
  • Purity target: ≥98% by HPLC (third-party verified per lot, both peptides)
  • Physical form: lyophilized white to off-white powder in a single sealed vial
  • Reconstitution: commonly reconstituted with bacteriostatic water for laboratory work

Why the pairing is studied in research

CJC-1295 and Ipamorelin act on two different receptors on the pituitary somatotroph, producing complementary signals:

  • CJC-1295 (GHRH-receptor pathway) — activates the GHRH receptor via Gs/cAMP/PKA signaling, driving pulsatile GH release (Teichman et al., 2006; Alba et al., 2006)
  • Ipamorelin (GHS-R1a pathway) — selectively binds the ghrelin receptor, with GH-releasing potency comparable to GHRP-6 but minimal cortisol, ACTH, or prolactin stimulation (Raun et al., 1998)
  • Combined activity — the dual-receptor stimulation is a common protocol design in GH-axis and IGF-1 activation research

Preclinical research areas

  • Dose-dependent GH and IGF-1 elevation via GHRH-receptor / Gs / cAMP / PKA signaling (Teichman et al., 2006)
  • Preservation of pulsatile GH secretion during continuous GHRH-receptor stimulation (Alba et al., 2006)
  • Albumin-bioconjugation (DAC) mechanism extending CJC-1295 half-life to approximately 6–8 days in pituitary GRF-receptor activation studies (Jetté et al., 2005)
  • Selective GHS-R1a binding and GH-releasing potency comparable to GHRP-6 in rat and swine models (Raun et al., 1998)
  • Minimal cortisol, ACTH, and prolactin stimulation relative to earlier-generation GH secretagogues in receptor-selectivity profiling
  • Longitudinal bone growth and bone mineral content changes in rodent GH-axis research
  • Serum proteomic biomarker changes associated with GH/IGF-1 axis activation (Sackmann-Sala et al., 2009)

Purity, testing, and COA

Every lot of the CJC-1295 / Ipamorelin Blend is characterized by an independent third-party laboratory. Each COA reports identity of both peptides by mass spectrometry, combined purity by reverse-phase HPLC, and appearance. Current and prior lot COAs are available at /pages/coas.

Handling and reconstitution

  • Store the sealed lyophilized vial at −20 °C, protected from light and moisture
  • Reconstitute with bacteriostatic water or sterile water per your laboratory SOP
  • After reconstitution, refrigerate at 2–8 °C and aliquot to single-use volumes
  • Record lot number, reconstitution date, and solvent for reproducibility
  • See the full SBR Labs handling & storage reference

Related research materials

For Laboratory Research Use Only. Not for human or veterinary use. Not a drug, dietary supplement, or cosmetic. Not intended to diagnose, treat, cure, or prevent any disease. Not for in-vivo use of any kind outside of a controlled research setting. Keep out of reach of children. By purchasing, you certify that you are a qualified researcher or research institution acquiring this product solely for in vitro laboratory research, and that you accept sole responsibility for compliance with all applicable local, state, and federal laws and regulations.